evo真人视讯

Exchange Visit Builds Synergy, Jointly Promoting New Industry Development – The Medical and Health Branch of Shenzhen Youth Science and Technology Association Visits Shenzhen Cell Valley

Date:05-25  Hits:  Belong to:News

图片.png

On May 23, a delegation from the Medical and Health Branch of the Shenzhen Youth Science and Technology Talent Association (hereinafter referred to as the "Medical and Health Branch") visited Shenzhen Cell Valley for exchange. The delegation included Chen Jie'an, Party Branch Secretary of the Beipu Center and Pingshan Center of Shenzhen Bay Laboratory; Cheng Yi, Senior Head of the Shenzhen Branch of Zhejiang BrainCo Technology Co., Ltd.; Huang Feijuan, Researcher at Shenzhen Second People's Hospital; Huang Jingzhou, Medical Director of Shenzhen Guangyu Biotechnology Co., Ltd.; Jiang Hequn, Chief Physician of the Traditional Chinese Medicine Department at the South China Hospital Affiliated to Shenzhen University; Liu Boxun, General Manager of Huaqing Zhimei (Shenzhen) Biotechnology Co., Ltd.; Wang Jun, Program Director at Shenzhen Polytechnic; and Zhang Lijun, Biotechnology Program Mentor at Shenzhen Polytechnic. Shenzhen Cell Valley Chairman and President of the Medical and Health Branch Shi Yuanyuan, Chief Scientist Wang Jianxun, Assistant to the Chairman Wei Zheng, Director of the General Administration Office Luan Zhishi, and Deputy Head of R&D Sun Rui extended a warm welcome.

图片.png图片.png

Assistant to the Chairman Wei Zheng led the delegation on a tour of Shenzhen Cell Valley's smart exhibition hall, introducing the founder team, industry prospects, corporate culture, development history, and platform development. A symposium was subsequently held.

图片.png图片.png

During the symposium, participants from the medical and health field actively exchanged views and discussed directions and approaches for jointly promoting industry development.

图片.png

Shi Yuanyuan, President of the Medical and Health Branch and Chairman of Shenzhen Cell Valley, stated that the vision of the Medical and Health Branch is to create a platform for communication, exchange, and resource sharing for young talent striving in Shenzhen, as well as for universities, institutions, enterprises, and individuals in the medical and health field. It aims to broaden the horizons of talent in related fields and continuously promote industrial upgrading and achievement translation. At the same time, as an emerging field, biomedicine requires strengthened industry-academia-research cooperation and focused talent cultivation, which will become an important safeguard for promoting the high-quality development of the cell and gene therapy industry. As a major public service platform for Shenzhen's biopharmaceutical industry, Shenzhen Cell Valley will enhance university-enterprise cooperation, assisting basic research talent in developing more high-quality translational projects with market demand and broad application prospects. When universities pass the baton of talent cultivation to enterprises, Shenzhen Cell Valley will provide further training, clarify talent cultivation goals, help talent realize their own value, form a comprehensive talent cultivation mechanism, and elevate the professional level and technical strength of the entire industry.

Zhong Chengzi, Secretary-General of the Medical and Health Branch, stated on behalf of the Secretariat that the Association will fully leverage its bridging role to help resolve issues in enterprise resource matching and exchange cooperation, help enterprises break down barriers, promote scientific and technological innovation exchanges, and achieve cross-domain resource integration. Yu Yuanzhi, Secretary-General of the Shenzhen Youth Science and Technology Association, expressed affirmation and expectations for the work of the Medical and Health Branch on behalf of the Association.

The exchange visit concluded successfully, with all participating units enhancing mutual understanding, laying a solid foundation for future win-win cooperation and jointly promoting high-quality industry development.


 图片.png

About the Shenzhen Youth Science and Technology Talent Association

The Shenzhen Youth Science and Technology Talent Association was approved by the Shenzhen Civil Affairs Bureau and established in May 1996. It is a social organization under the leadership of the Communist Youth League Shenzhen Municipal Committee, providing relevant services to young scientific and technological talent and science and technology enterprises and institutions throughout the city.

Through building a comprehensive innovation and entrepreneurship service platform, a government-industry-academia-research resource matching platform, and a learning and growth platform for young talent, the Association broadly unites young scientific and technological workers to support Shenzhen's construction and development. At the same time, in response to members' urgent needs for cross-sector, cross-regional, and cross-industry development, it organizes "Into Science and Technology" series activities, "Government-Enterprise Face to Face" series activities, industry-academia-research resource matching activities, and youth innovation salons.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@rodael.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software